We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATCX
2951
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $439K | ﹤0.01% |
66,026
-2,263
| -3% | -$16.2K |
|
2952
Playboy Inc
PLBY
$141M
| $437K | ﹤0.01% |
108,337
+7,054
| +7% | +$37.9K |
|
2953
Celularity
CELU
$20.3M
| $432K | ﹤0.01% |
18,687
+8,584
| +85% | +$260K |
|
2954
NI Holdings
NODK
$320M
| $432K | ﹤0.01% |
32,349
-90
| -0.3% | -$1.3K |
|
2955
SelectQuote
SLQT
$121M
| $432K | ﹤0.01% |
591,507
-5,221
| -0.9% | -$8.68K |
|
2956
Finance of America Companies
FOA
$198M
| $430K | ﹤0.01% |
29,101
-5
| -0% | -$79 |
|
2957
Riley Exploration Permian
REPX
$758M
| $429K | ﹤0.01% |
22,611
-17,832
| -44% | -$437K |
|
|
BGRY
2958
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $429K | ﹤0.01% |
252,384
+11,617
| +5% | +$23.2K |
|
2959
Aveanna Healthcare
AVAH
$2.07B
| $427K | ﹤0.01% |
284,736
-46,382
| -14% | -$95.3K |
|
|
LTCH
2960
DELISTED
Latch, Inc. Common Stock
LTCH
| $427K | ﹤0.01% |
446,911
+63,552
| +17% | +$72.9K |
|
|
PFSW
2961
DELISTED
PFSweb, Inc.
PFSW
| $424K | ﹤0.01% |
45,493
-49
| -0.1% | -$505 |
|
2962
Hovnanian Enterprises
HOV
$807M
| $422K | ﹤0.01% |
11,830
-454
| -4% | -$20.1K |
|
2963
The ONE Group
STKS
$53M
| $420K | ﹤0.01% |
63,155
-155
| -0.2% | -$1.2K |
|
2964
Superior Group of Companies
SGC
$225M
| $416K | ﹤0.01% |
46,844
+801
| +2% | +$11.5K |
|
2965
Digimarc Corp
DMRC
$178M
| $415K | ﹤0.01% |
30,653
| – | – |
|
|
AKTS
2966
DELISTED
Akoustis Technologies Inc
AKTS
| $415K | ﹤0.01% |
139,682
+5,322
| +4% | +$21.6K |
|
2967
BRC Inc
BRCC
$250M
| $412K | ﹤0.01% |
53,280
-148
| -0.3% | -$1.34K |
|
|
CONN
2968
DELISTED
Conn's Inc.
CONN
| $406K | ﹤0.01% |
57,389
-1,734
| -3% | -$16.5K |
|
2969
HBT Financial
HBT
$1.32B
| $404K | ﹤0.01% |
22,238
| – | – |
|
2970
Quad
QUAD
$525M
| $402K | ﹤0.01% |
157,238
-5,832
| -4% | -$19.1K |
|
|
TEAD
2971
Teads Holding Co
TEAD
$66.9M
| $400K | ﹤0.01% |
109,605
-397
| -0.4% | -$1.93K |
|
2972
Ouster
OUST
$2.92B
| $399K | ﹤0.01% |
41,431
-152
| -0.4% | -$2.34K |
|
2973
Dakota Gold
DC
$804M
| $396K | ﹤0.01% |
129,834
-537
| -0.4% | -$1.98K |
|
|
CMBM
2974
DELISTED
Cambium Networks
CMBM
| $394K | ﹤0.01% |
23,304
| – | – |
|
|
API
2975
Agora
API
$377M
| $390K | ﹤0.01% |
107,500
+29,500
| +38% | +$140K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.